Aestis Introduces an Innovative, Non-Invasive Treatment and Prevention of Obesity Using Controlled Hypoxia.BOULDER, Colo. -- Aestis, Inc., the developers of the ThinAir(TM) system, a controlled hypoxia hypoxia Condition in which tissues are starved of oxygen. The extreme is anoxia (absence of oxygen). There are four types: hypoxemic, from low blood oxygen content (e.g., in altitude sickness); anemic, from low blood oxygen-carrying capacity (e.g. treatment of obesity, announces that they will be presenting at the In3 Medical Device Summit on Thursday June 22, 2006, at 3:30 p.m. PDT PDT abbr. Pacific Daylight Time PDT Pacific Daylight Time PDT n abbr (US) (= Pacific Daylight Time) → hora de verano del Pacífico PDT . The conference, sponsored by Medtech Insight, will be held at The Palace Hotel in San Francisco, CA, from June 21 - 23, 2006. Investors and researchers interested in learning more about this non-invasive treatment for the obese and overweight are invited to attend. Patients sleep in the ThinAir system tent and function normally during the rest of the day, without having to restrict their diet or increase their physical activity. A feasibility study "A Feasibility Study" is an episode of the original The Outer Limits television show. It first aired on 13 April, 1964, during the first season. It was remade in 1997 as part of the revived The Outer Limits series with a minor title change. has been conducted with favorable results and no side effects Side effects Effects of a proposed project on other parts of the firm. . Aestis sponsored the study that was conducted by Wim H.M. Saris SARIS Search and Rescue Information System SARIS Scattering And Recoiling Imaging Spectrometry SARIS Savannah River Simulator SARIS Spatial/Spectral Airborne Radiometric Imaging Spectrometer (Spectral imaging system used at Eglin AFB) , M.D., Ph.D., a world renowned nutrition expert at Maastricht University in the Netherlands. The results showed that average weight loss was greater than one pound per week. The protocol involved two weeks of nightly exposure for an average of 7.2 hours per night to a simulated altitude of 4200M. The weight loss continued throughout the study for subjects who used the system for a total of six weeks. The therapy was safe for all subjects, and no subjects had to withdraw from the study for health reasons. Acceptance was high and many subjects expressed desire to continue using the therapy after the initial six week trial. Dr. Saris concluded, "At altitude (hypoxia) loss of appetite loss of appetite Medtalk Anorexia, see there and consequently weight is observed. It has been studied and proven for over 50 years. This gives a strong scientific foundation for Aestis." Dede Willis, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Aestis, has over 20 years of management and operating experience, including several executive positions in Europe and the U.S. within the life sciences industry. She was CEO of a $100 million subsidiary of Hoechst AG (Sanofi Aventis) and also of Proligo Biochemie GmbH (Degussa AG). She will be presenting the ThinAir system at the In3 Medical Device Summit on Thursday June 22, 2006 at 3:30 p.m. PDT. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion